Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey

Fig. 3

a Most common psychiatrist-reported reasons for prescribing patients’ current schizophrenia treatment. LAI: long-acting injectable; US, United States b Most common psychiatrist-reported reasons for switching patients’ previous schizophrenia treatment LAI: long-acting injectable; US, United States

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us